PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 36 filers reported holding PROTARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,785 | -33.3% | 34,602 | -4.5% | 0.00% | – |
| Q2 2023 | $86,610 | -25.4% | 36,238 | -2.3% | 0.00% | – |
| Q1 2023 | $116,099 | +19.1% | 37,092 | +2.0% | 0.00% | – |
| Q4 2022 | $97,445 | -7.2% | 36,360 | +2.4% | 0.00% | – |
| Q3 2022 | $105,000 | -7.1% | 35,501 | -7.8% | 0.00% | – |
| Q2 2022 | $113,000 | -43.5% | 38,508 | -1.0% | 0.00% | – |
| Q1 2022 | $200,000 | -26.2% | 38,916 | -3.0% | 0.00% | – |
| Q4 2021 | $271,000 | -11.4% | 40,140 | -8.8% | 0.00% | – |
| Q3 2021 | $306,000 | -21.7% | 44,036 | +9.7% | 0.00% | – |
| Q2 2021 | $391,000 | -86.9% | 40,125 | -78.9% | 0.00% | – |
| Q1 2021 | $2,988,000 | -32.2% | 189,876 | +4.4% | 0.00% | – |
| Q4 2020 | $4,404,000 | +183.8% | 181,888 | +97.2% | 0.00% | – |
| Q3 2020 | $1,552,000 | -42.7% | 92,232 | -0.2% | 0.00% | – |
| Q2 2020 | $2,708,000 | – | 92,384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,558,472 | $43,059,000 | 8.42% |
| CVI Holdings, LLC | 168,836 | $2,842,000 | 1.16% |
| Soleus Capital Management, L.P. | 100,000 | $1,683,000 | 0.89% |
| Ikarian Capital, LLC | 722,443 | $12,158,000 | 0.88% |
| COWEN AND COMPANY, LLC | 124,171 | $2,090,000 | 0.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 782,670 | $13,172,000 | 0.32% |
| Cormorant Asset Management, LP | 450,000 | $7,574,000 | 0.29% |
| Rock Springs Capital Management LP | 643,622 | $10,832,000 | 0.28% |
| Perceptive Advisors | 608,544 | $10,242,000 | 0.15% |
| Maven Securities LTD | 100,000 | $1,688,000 | 0.14% |